Precision Medicine and Pharmacogenomics Reshape Modern Healthcare
Precision medicine is changing how doctors treat disease.
It focuses on individual differences.
Genes play a central role.
Traditional medicine follows a one-size-fits-all model.
However, patients often respond differently.
Side effects can vary widely.
Precision medicine aims to solve this gap.
It uses genetic, environmental, and lifestyle data.
Treatments become more targeted.
Pharmacogenomics is a key pillar.
It studies how genes affect drug response.
The goal is safer and more effective therapy.
Some genes influence drug metabolism.
Others affect drug targets.
Small genetic changes can alter outcomes.
As a result, the same drug dose may not suit everyone.
One patient may benefit.
Another may face adverse reactions.
Pharmacogenomic testing helps guide decisions.
Doctors can choose the right drug earlier.
They can also adjust doses accurately.
Cancer care leads this shift.
Targeted therapies match specific mutations.
Outcomes have improved in many cases.
Cardiology and psychiatry also benefit.
Blood thinners and antidepressants show gene-linked responses.
Personalisation reduces trial and error.
Technology drives progress.
Genome sequencing is faster and cheaper.
Data analysis tools continue to improve.
However, challenges remain.
Testing access is uneven.
Data privacy concerns persist.
Clinical adoption also takes time.
Doctors need training.
Guidelines must evolve.
Despite hurdles, momentum is strong.
Healthcare systems see long-term value.
Prevention and efficiency improve.
Precision medicine promises smarter care.
Pharmacogenomics supports safer prescribing.
Together, they signal a shift toward truly personalised treatment.
CMP Bio World 